Politico February 20, 2024
GAPS IN AUTHORITY — President Joe Biden has promised a coordinated — and fast — response from his agencies to ensure artificial intelligence safety and efficacy. But regulators like the FDA don’t have the resources they need to preside over technology that, by definition, is constantly changing, POLITICO’s Ruth Reader reports.
And that lack of resources is a major reason the government hasn’t yet regulated the advanced AI that’s remaking health care.
What’s the hang-up? AI advancements have created significant FDA regulatory gaps. Though the agency treats first-gen AI tools as it does other medical devices, it doesn’t review products like chatbots and has no authority over systems that summarize doctors’ notes and perform other critical administrative tasks.
FDA Commissioner...
Today's Sponsors
Today's Sponsor